SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PACIARONI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.238
AS - Asia 6.091
EU - Europa 4.050
SA - Sud America 1.341
Continente sconosciuto - Info sul continente non disponibili 551
AF - Africa 240
OC - Oceania 42
Totale 22.553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.557
IT - Italia 2.208
SG - Singapore 1.616
BD - Bangladesh 1.548
BR - Brasile 976
CN - Cina 706
HK - Hong Kong 704
VN - Vietnam 631
CA - Canada 399
NL - Olanda 365
GB - Regno Unito 255
DE - Germania 207
FR - Francia 206
JP - Giappone 184
IN - India 151
FI - Finlandia 124
AR - Argentina 113
RU - Federazione Russa 95
MX - Messico 83
EC - Ecuador 77
ZA - Sudafrica 74
ES - Italia 73
ID - Indonesia 73
UA - Ucraina 72
BE - Belgio 61
JM - Giamaica 58
PL - Polonia 58
IQ - Iraq 57
AE - Emirati Arabi Uniti 56
CO - Colombia 54
TR - Turchia 52
AT - Austria 47
PT - Portogallo 47
PK - Pakistan 46
EG - Egitto 42
VE - Venezuela 38
AU - Australia 37
SE - Svezia 35
IE - Irlanda 34
CR - Costa Rica 33
HU - Ungheria 33
MY - Malesia 33
PH - Filippine 31
TW - Taiwan 30
MA - Marocco 28
CL - Cile 26
UZ - Uzbekistan 26
SA - Arabia Saudita 24
LT - Lituania 23
HN - Honduras 22
PY - Paraguay 21
TN - Tunisia 21
NI - Nicaragua 18
TT - Trinidad e Tobago 18
EE - Estonia 17
PE - Perù 17
CH - Svizzera 16
KE - Kenya 15
NP - Nepal 15
DZ - Algeria 14
BO - Bolivia 13
IL - Israele 13
KZ - Kazakistan 13
NO - Norvegia 13
ET - Etiopia 12
JO - Giordania 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
RO - Romania 9
OM - Oman 8
BB - Barbados 7
IR - Iran 7
PA - Panama 7
PR - Porto Rico 7
TH - Thailandia 7
DK - Danimarca 6
GR - Grecia 6
UY - Uruguay 6
AL - Albania 5
AM - Armenia 5
HR - Croazia 5
KG - Kirghizistan 5
NG - Nigeria 5
PS - Palestinian Territory 5
RS - Serbia 5
BY - Bielorussia 4
GT - Guatemala 4
KR - Corea 4
LA - Repubblica Popolare Democratica del Laos 4
SV - El Salvador 4
AO - Angola 3
BG - Bulgaria 3
CG - Congo 3
CI - Costa d'Avorio 3
GE - Georgia 3
LV - Lettonia 3
LY - Libia 3
SN - Senegal 3
TZ - Tanzania 3
Totale 21.953
Salva come PNG Salva come JPEG
Città #
Ashburn 1.359
Council Bluffs 1.052
San Jose 1.002
Singapore 826
Hong Kong 696
New York 576
Los Angeles 335
Dallas 334
Milan 254
Ho Chi Minh City 208
Beijing 207
Santa Clara 180
Tokyo 173
Hanoi 163
Chicago 157
Rome 146
Buffalo 124
Toronto 105
Amsterdam 98
Bologna 98
North Bergen 92
São Paulo 91
Naples 90
Phoenix 88
Atlanta 78
Orem 76
Helsinki 73
Montreal 71
Lauterbourg 70
San Francisco 60
Denver 58
Turin 58
Utrecht 53
Warsaw 52
Florence 48
Hefei 48
Brooklyn 46
Quito 44
Bari 40
Abu Dhabi 39
Figino 38
Groningen 38
Lisbon 38
Mexico City 38
Frankfurt am Main 37
Boston 36
Lappeenranta 36
Palermo 36
Miami 35
Charlotte 34
Nuremberg 34
Da Nang 33
London 33
Seattle 33
Houston 32
Poplar 32
Haiphong 31
Budapest 30
Paris 29
Vancouver 29
Baghdad 28
Barcelona 28
Boardman 28
Mulhouse 28
Kingston 27
Philadelphia 27
Salt Lake City 27
Stockholm 27
De Lier 26
Dublin 26
Tampa 25
Brasília 24
Cairo 24
Des Moines 24
Dhaka 24
Rio de Janeiro 24
Belo Horizonte 23
Ferrara 23
Taichung 23
Washington 23
San José 22
Tashkent 22
Curitiba 21
Johannesburg 21
Sydney 21
Genoa 20
Pasadena 20
Catania 19
Hải Dương 19
Memphis 19
Falkenstein 18
Guayaquil 18
Madrid 18
Newark 18
Shanghai 18
Cagliari 17
Chennai 17
Kuala Lumpur 17
Managua 17
Naaldwijk 17
Totale 10.938
Salva come PNG Salva come JPEG
Nome #
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 1.296
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 630
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke 375
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 267
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 224
Desmoteplase 204
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 193
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 189
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults 176
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging – Results from the READAPT study 173
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin 171
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry 160
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 159
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 159
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 158
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy 151
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 145
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 139
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 139
Timing of anticoagulation therapy in patients with acute ischemic stroke and atrial fibrillation: a GRADE-based expert opinion recommendation 138
Age- and sex-specific analysis of patients with embolic stroke of undetermined source 136
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 135
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial 131
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy 128
Long-term outcome of cervical artery dissection : IPSYS CeAD: study protocol, rationale, and baseline data of an Italian multicenter research collaboration 128
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study) 127
Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 127
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 127
Risk Profile of Patients with Spontaneous Cervical Artery Dissection 126
Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy 126
Un caffè tra due amici al bar. L'esame obiettivo neurologico 125
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-Analysis 122
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection 121
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 121
Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis 120
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 120
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome 117
Treatments in Ischemic Stroke: Current and Future 116
Secondary stroke prevention in people with atrial fibrillation: treatments and trials 115
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT Study 113
A tool to identify patients with embolic stroke of undetermined source at high recurrence risk 113
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 113
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 113
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis 112
History of cardiac embolism 112
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both? 110
History of stroke 109
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 109
Pure sensory syndromes in thalamic stroke 107
Medical versus neurosurgical treatment in ICH patients: a single center experience 107
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 107
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial 105
Profilassi secondaria nel paziente con attacco ischemico transitorio o ictus aterotrombotico carotideo [Secondary prevention in patients with transient ischemic attack or stroke due to carotid atherosclerosis] 104
Comparative study of venous thromboembolic prophylaxis strategies in hemorrhagic stroke: A systematic review and network meta-analysis 103
Consensus paper on the management of acute isolated vertigo in the emergency department 103
Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia 102
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome 100
Predictors of severe intracerebral hemorrhage expansion 99
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke 99
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis: Analysis of the ACTION CVT 98
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 98
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 98
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 97
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis 97
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 97
Visual experiences of Blaise Pascal 96
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant dta meta-analysis 96
Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment 96
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 94
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke 93
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 93
Sex-related differences in clinical characteristics, treatment and outcomes in patients with atrial fibrillation and acute ischemic stroke treated with non-vitamin-K antagonists 93
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models 92
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage 92
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score 91
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 89
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack 89
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 88
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study 88
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 87
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 86
Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies 85
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials 85
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 85
The turning point in stroke investigation for neurologists 84
Anticoagulation After Stroke in Patients With Atrial Fibrillation 84
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 83
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS) 82
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013] 82
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion 81
Semeiotica e gestione delle urgenze neurologiche 81
Migraine improvement after spontaneous cervical artery dissection the Italian Project on Stroke in Young Adults (IPSYS) 81
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study 80
A case of typical headache with an atypical diagnosis 80
Migraine and Cryptogenic Ischemic Stroke 77
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 77
Acute stroke symptoms: Do differences exist between sexes? 76
The concept of ischemic penumbra in acute stroke and therapeutic opportunities 76
Carotid dissection and carotid occlusion with stroke: neuro-ophtalmological manifestations 76
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study 75
Totale 13.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.003
Totale 87.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 5 1 0 3 0 0 0 2 4
2022/20238 2 1 0 0 0 0 1 0 1 2 0 1
2023/20246 1 0 0 0 1 0 0 0 0 0 0 4
2024/20252.068 0 0 4 0 2 78 395 315 224 524 271 255
2025/202614.178 571 675 1.161 1.559 1.337 480 789 616 1.055 1.611 1.988 2.336
2026/20276.210 1.364 944 1.487 2.415 0 0 0 0 0 0 0 0
Totale 22.553